Home / Program / 4/27 (Sat) / Oral Presentation 5
Oral Presentation 5

Category: Tuberculosis (TB)- Drug-Resistant TB

Date: Saturday, Apr 27, 2024 | Time: 13:30-14:40 (GMT+8)
Presentation Serial Number Title Presenter
OP-05-01 HIGH-DOSE LINEZOLID: ADVERSE EVENTS AND OUTCOMES DURING BPAL

IMPLEMENTATION FOR PRE-EXTENSIVELY DRUG RESISTANT TB OR FAILED/INTOLERANT RIFAMPICIN RESISTANT TB PATIENTS IN VIETNAM

Mrs. Thi-Mai-Phuong Nguyen
OP-05-02 ELEVATED PRETOMANID MINIMUM INHIBITORY CONCENTRATION AND TREATMENT OUTCOME OF TUBERCULOSIS PATIENTS Dr. Jeya Deepa Bharathi
OP-05-03 SAFETY OF SHORTER ORAL MODIFIED BPAL REGIMEN IN MANAGEMENT OF PRE-EXTENSIVELY DRUG RESISTANT TUBERCULOSIS – INTERIM ANALYSIS Dr. Balaji Ramraj
OP-05-04 IMPLEMENTING SHORTER-TREATMENT REGIMENS FOR DRUG-RESISTANT TUBERCULOSIS UNDER OPERATIONAL STUDY CONDITIONS IN TAJIKISTAN: PRELIMINARY RESULTS ON TREATMENT OUTCOMES Dr. Zumrad Maxumova
OP-05-05 DOES SAME DURATION OF TREATMENT FOR PREXDR TB PATIENTS MANAGED WITH SHORTER ORAL BEDAQUILINE CONTAINING REGIMENS SUFFICE FOR ALL? – A POINT TO PONDER Dr. Balaji Ramraj
OP-05-06 TRENDS IN MULTIDRUG-RESISTANT TUBERCULOSIS IN TAIWAN: INSIGHTS FROM REPORTED DATA, 2008-2022 Ms. Mei-Mei Kuan
OP-05-07 EXPLORING AMPLIFICATION OF DRUG-RESISTANCE TB IN TAIWAN USING WHOLE GENOME SEQUENCING DATA Ms. Chieh-Yin (Jenny) Wu